Liposomes as a Promising Ultrasound-Triggered Drug Delivery System in Cancer Treatment

Curr Mol Med. 2017;17(10):668-688. doi: 10.2174/1566524018666180416100142.

Abstract

The initial uses of ultrasound waves in the medical field were limited to the thermal ablation of solid tumors and as a diagnostic tool. Recent advances at the preclinical stage have allowed the use of ultrasound as a powerful tool to improve drug delivery when the agent is administered encapsulated inside a nanoparticle. This spatial and temporal control of drug release, using a non-invasive modality, is a promising approach to decrease the side effects of conventional chemotherapy in cancer treatments, as it reduces the interaction of the anti-neoplastic agent with healthy tissues. In this review, we explain the physics of ultrasound, introduce and discuss several examples on the use of nanoparticles as drug carriers, with a focus on liposomes. Examples of in vitro and in vivo studies are presented and discussed.

Keywords: Cancer; anti-neoplastic agent; drug delivery; drug release; liposomes; ultrasound..

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacology
  • Drug Carriers
  • Drug Delivery Systems*
  • Humans
  • Liposomes / administration & dosage*
  • Liposomes / chemistry
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Neoplasms / drug therapy*
  • Ultrasonics*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Liposomes